DE69531712D1 - Hybridgel, das eine biologisch aktive Substanz sekretiert - Google Patents

Hybridgel, das eine biologisch aktive Substanz sekretiert

Info

Publication number
DE69531712D1
DE69531712D1 DE69531712T DE69531712T DE69531712D1 DE 69531712 D1 DE69531712 D1 DE 69531712D1 DE 69531712 T DE69531712 T DE 69531712T DE 69531712 T DE69531712 T DE 69531712T DE 69531712 D1 DE69531712 D1 DE 69531712D1
Authority
DE
Germany
Prior art keywords
secretes
active substance
biologically active
hybrid gel
hybrid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69531712T
Other languages
English (en)
Other versions
DE69531712T2 (de
Inventor
Susumu Yoshida
Andrew R Cuthbertson
Katsutoshi Yoshizato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japan Science and Technology Agency
Genentech Inc
Original Assignee
Japan Science and Technology Corp
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Science and Technology Corp, Genentech Inc filed Critical Japan Science and Technology Corp
Publication of DE69531712D1 publication Critical patent/DE69531712D1/de
Application granted granted Critical
Publication of DE69531712T2 publication Critical patent/DE69531712T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/126—Immunoprotecting barriers, e.g. jackets, diffusion chambers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69531712T 1994-04-25 1995-04-25 Hybridgel, das eine biologisch aktive Substanz sekretiert Expired - Fee Related DE69531712T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP8697994 1994-04-25
JP8697994 1994-04-25
JP28848794 1994-11-22
JP28848794 1994-11-22

Publications (2)

Publication Number Publication Date
DE69531712D1 true DE69531712D1 (de) 2003-10-16
DE69531712T2 DE69531712T2 (de) 2004-07-01

Family

ID=26428061

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69531712T Expired - Fee Related DE69531712T2 (de) 1994-04-25 1995-04-25 Hybridgel, das eine biologisch aktive Substanz sekretiert

Country Status (5)

Country Link
US (1) US6485721B1 (de)
EP (1) EP0679402B1 (de)
AU (1) AU1766595A (de)
CA (1) CA2147810A1 (de)
DE (1) DE69531712T2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9715085D0 (en) 1997-07-18 1997-09-24 Jahoda Amanda J Gene therapy vehicle
US20060258562A1 (en) * 2000-07-31 2006-11-16 Healor Ltd. Methods and pharmaceutical compositions for healing wounds
US20040037828A1 (en) 2002-07-09 2004-02-26 Bar-Ilan University Methods and pharmaceutical compositions for healing wounds
US20100129332A1 (en) * 2000-07-31 2010-05-27 Tamar Tennenbaum Methods and pharmaceutical compositions for healing wounds
ATE429925T1 (de) * 2000-07-31 2009-05-15 Univ Bar Ilan Methoden und pharmazeutische zusammensetzungen zur wundheilung
AU2002229823B2 (en) 2001-04-04 2007-02-15 Delsitech Oy Biodegradable carrier and method for preparation thereof
US8088568B2 (en) * 2001-11-05 2012-01-03 Medgentics, Inc. Dermal micro-organs, methods and apparatuses for producing and using the same
US7468242B2 (en) * 2001-11-05 2008-12-23 Medgenics, Inc. Dermal micro organs, methods and apparatuses for producing and using the same
US8501396B2 (en) 2001-11-05 2013-08-06 Medgenics Medical Israel Ltd. Dermal micro-organs, methods and apparatuses for producing and using the same
WO2004099363A2 (en) 2003-05-01 2004-11-18 Medgenics Inc. Dermal micro organs, methods and apparatuses for producing and using the same
ATE529125T1 (de) * 2003-08-07 2011-11-15 Healor Ltd Pharmazeutische zusammensetzungen und verfahren zur beschleunigung der wundheilung
CA2625674C (en) * 2005-08-29 2015-04-14 Healor Ltd. Methods and compositions for prevention and treatment of diabetic and aged skin
KR101449587B1 (ko) * 2006-09-14 2014-10-10 메드제닉스 메디칼 이스라엘 리미티드 장기 지속형 약물 제형
US8454948B2 (en) 2006-09-14 2013-06-04 Medgenics Medical Israel Ltd. Long lasting drug formulations
KR101397912B1 (ko) * 2009-02-24 2014-05-29 힐로 리미티드 여드름 및 기타 질환 치료용 비스파틴 치료제
CA2789972A1 (en) 2010-01-11 2011-07-14 Healor Ltd. Method for treatment of inflammatory disease and disorder
CN103260649A (zh) 2010-06-15 2013-08-21 迈德詹尼克斯医疗以色列有限公司 长效药物制剂

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4485096A (en) * 1982-02-26 1984-11-27 Massachusetts Institute Of Technology Tissue-equivalent and method for preparation thereof
AU589438B2 (en) * 1985-08-26 1989-10-12 Hana Biologics, Inc. Transplantable artificial tissue and process
US5219740A (en) * 1987-02-13 1993-06-15 Fred Hutchinson Cancer Research Center Retroviral gene transfer into diploid fibroblasts for gene therapy
CA1341356C (en) * 1987-05-01 2002-04-09 Richard F. Selden Transkaryotic implantation
EP0378576B1 (de) * 1987-09-11 1995-01-18 Whitehead Institute For Biomedical Research Transduktionsveränderte fibroblasten und ihre anwendung
EP0363125A3 (de) * 1988-10-03 1990-08-16 Hana Biologics Inc. Produkt, enthaltend vermehrungsfähige Bauchspeicheldrüsen-Endokrinezellen, und Verfahren
FR2650951A1 (fr) * 1989-08-17 1991-02-22 Grp Interet Public Thera Agents activateurs de la secretion de l'insuline support de culture cellulaires et bioimplants comprenant lesdits agents
DE69221484T2 (de) * 1991-04-25 1998-02-19 Univ Brown Res Found Implantierbare, biokompatible immunisolator-trägersubstanz zum abgeben ausgesuchter, therapeutischer produkte

Also Published As

Publication number Publication date
CA2147810A1 (en) 1995-10-26
EP0679402A2 (de) 1995-11-02
US6485721B1 (en) 2002-11-26
DE69531712T2 (de) 2004-07-01
EP0679402A3 (de) 1997-04-23
EP0679402B1 (de) 2003-09-10
AU1766595A (en) 1995-11-02

Similar Documents

Publication Publication Date Title
DE69531712D1 (de) Hybridgel, das eine biologisch aktive Substanz sekretiert
DE69434865D1 (de) Patientenpflegesystem
DE69530553D1 (de) Medizinisches polymergel
NO953838D0 (no) Fjernbart medisinsk elektrodesystem
DE69725373D1 (de) Aktives Implantat
NO902386D0 (no) Alginatgeler.
DE69014498D1 (de) Hyposensibilisierende wirksame Substanz.
IT9022477A0 (it) Gel cataliticamente attivo e procedimento per la preparazione
FI891886A (fi) Anti-inflammatorisk gel.
NO940801D0 (no) Forskalling
NO970258D0 (no) Dobbelt hybrid system
NO870533L (no) Terapeutisk aktive 3-alkoksy-2-aminopropylaminer.
DK0811593T3 (da) 1,4-diaryl-2-flour-2-buten som insektcider og acaricider
NO910022L (no) Fungizide virkestoffkombinasjoner.
DE69100165D1 (de) Aufreissbarer versandsumschlag.
DE68912252D1 (de) Imidazolantiarrythmische Mittel.
TR199501336A2 (tr) Talim tertibati.
FR2715945B1 (fr) Tissu.
DE3787371D1 (de) Biologisch aktives mittel.
ATA185996A (de) Pflegewagen
IT242042Y1 (it) Contenitore in ovatta sterile.
DK48194A (da) Medicinsk elektrode
ATE94067T1 (de) Biologisch aktives mittel.
KR960017605U (ko) 애노드 교환장치
ITRM930691A0 (it) Stazione audiometrica computerizzata.

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: JAPAN SCIENCE AND TECHNOLOGY CORP., KAWAGUCHI, SAI

Owner name: GENENTECH, INC., SOUTH SAN FRANCISCO, CALIF., US

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee